2026
Patent applications filed for Cissuslean®
Star Hi Herbs has expanded the IP programme supporting Cissuslean® with Indian Application No. 202641021756, PCT Application No. PCT/IB2026/054903 and US Application No. 19/716,179.
Read more →News & Press
News & Press
Follow the latest developments from Cissuslean® and Star Hi Herbs — peer-reviewed research, clinical study updates, IP announcements and industry events.
Press releases
2025
Cissuslean® clinical research programme advances
Two randomized, double-blind, placebo-controlled human studies have evaluated Cissuslean® for weight and body-fat management and for supporting adults with knee osteoarthritis. Manuscripts are currently under preparation.
Read more →Publications
15 April 2025
Preclinical joint-health study published in Food & Nutrition Research
A Cissus quadrangularis extract containing quercetin and isorhamnetin was evaluated in a rat model of osteoarthritis, examining inflammation, cartilage integrity and subchondral bone health.
2025
Cissuslean® anti-obesity study published
Published in Journal of Food and Nutrition Research 13(1):9–17: Cissuslean® reduced lipid accumulation and modulated pathways associated with adipogenesis and fatty-acid metabolism.
Trade shows & events
Upcoming
Meet the Star Hi Herbs team at leading nutraceutical and pharmaceutical industry events to discuss Cissuslean® research, formulation opportunities, technical documentation and commercial partnerships.
Schedule a meeting →Articles & insights
- Cissus quadrangularis for weight management: What does the research show?
- Cissuslean® dosage: Understanding clinically studied use levels
- How Cissuslean® supports a healthy body-composition strategy
- Cissus quadrangularis and joint health: Current scientific evidence
- Why standardization matters in Cissus quadrangularis extracts
- How to formulate Cissuslean® into capsules, tablets, powders and gummies
- Understanding the bioactive compounds in Cissuslean®
- The 2026 weight-management market: Trends and formulation opportunities